Darlene Noci
Corporate Officer/Principal bei NUVALENT, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Darlene Noci is the founder of Noci Strategic Consulting LLC, which was founded in 2018.
Currently, Ms. Noci is the Chief Development Officer at Nuvalent, Inc. since 2022.
Previously, Ms. Noci held the position of Head-Regulatory Affairs at AVEO Pharmaceuticals, Inc. Ms. Noci also served as the VP-Regulatory Affairs & Quality Assurance at X4 Pharmaceuticals, Inc. from 2016 to 2018, and as a Principal at EMD Serono, Inc. from 2014 to 2016.
Ms. Noci obtained a graduate degree from Harvard University and an undergraduate degree from Adelphi University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUVALENT, INC. CLASS A
0,06% | 22.03.2024 | 33 300 ( 0,06% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Darlene Noci
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVALENT, INC. | Corporate Officer/Principal | 20.07.2022 |
Ehemalige bekannte Positionen von Darlene Noci
| Unternehmen | Position | Ende |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | General Counsel | 01.05.2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01.01.2016 |
| Noci Strategic Consulting LLC | Founder | - |
| AVEO PHARMACEUTICALS, INC. | General Counsel | - |
Ausbildung von Darlene Noci
| Harvard University | Graduate Degree |
| Adelphi University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| X4 PHARMACEUTICALS, INC. | Health Technology |
| NUVALENT, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Noci Strategic Consulting LLC |
